Brainstorm Cell Therapeutics, Inc.

Brainstorm Cell Therapeutics, Inc.

Sector: Commercial Physical And Biological Research Region: NY, United States

: | OTC Markets: BCLI

Similar to: Exelixis, Inc., Cerep SA, Pierrel SpA

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NY.

News & Analysis

You may also be interested in: